Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1/Phase 2"
topic_facet:"Breast Neoplasms"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (220)
1
Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer : A Phase I/II Study of the SV-BR-1-GM Regimen in HLA Matched Metastatic Breast Cancer Patients in Combination With Pembrolizumab
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
2
S 81694 Plus Paclitaxel in Metastatic Breast Cancer : Phase I/II Trial of S 81694 Administered Intravenously in Combination With Paclitaxel to Evaluate the Safety, Pharmacokinetic and Efficacy in Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
3
Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer : A Phase 1/2, Open-Label, Dose-Escalation Study of ISB 1302 in Subjects With HER2-Positive Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
4
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers : A Phase 1/2a, Open-Label, Multi-Center Study Evaluating the Safety and Anti-Tumor Activity of Ex Vivo Expanded, Autologous Natural Killer Cells (SNK01) in Combination With Trastuzumab or Cetuximab in Subjects With Advanced/Metastatic HER2- or EGFR-Expressing Cancers
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
5
Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone : Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone, for Triple Negative Locally Advanced Breast Cancers and Luminal B Proliferating, Inaccessible to a Conservative Surgery the Outset
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
6
Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor. : A Phase I/II, Single Arm, Open-label Study of Ribociclib in Combination With Everolimus + Exemestane in the Treatment of Men and Postmenopausal Women With HR+, HER2- Locally Advanced or Metastatic Breast Cancer Following Progression on a CDK 4/6 Inhibitor
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
7
Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca : Phase II Study of Combination Ruxolitinib (INCB018242) With Preoperative Chemotherapy for Triple Negative Inflammatory Breast Cancer Following Completion of a Phase I Combination Study in Recurrent/Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
8
Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients : Neoadjuvant Therapy Study Guided by Drug Screening in Vitro Patient-derived Tumor-like Cell Clusters for HER2 Positive Early Breast Cancer Patients
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
9
QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy : NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
10
Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection : A Randomized, Multicenter, Phase I/IIa Clinical Study to Evaluate the Tolerability, Safety, Efficacy, Pharmacokinetics and Immunogenicity of GB221 for Injection for the Treatment of HER2-positive Breast Cancer Patients
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 1/Phase 2
Filter aufheben
Thema: Breast Neoplasms
Medienart
220
Aufsätze
220
E-Artikel
220
E-Ressourcen
Zeitschriftentitel
220
ClinicalTrials.gov
Thema
220
610
Breast Neoplasms
Phase: Phase 1/Phase 2
220
Study Type: Interventional
114
Recruitment Status: Completed
88
Medical Condition: Breast Cancer
45
Recruitment Status: Terminated
26
Medical Condition: Metastatic Breast Cancer
25
Recruitment Status: Unknown status
19
Recruitment Status: Withdrawn
13
Breast Neoplasms, Male
13
Triple Negative Breast Neoplasms
10
Carcinoma
9
Recruitment Status: Recruiting
8
Medical Condition: Breast Neoplasms
6
Pancreatic Neoplasms
5
Lung Neoplasms
5
Neoplasm Metastasis
5
Neoplasms
3
Carcinoma, Ductal
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
51
2020-
158
2010-2019
11
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
220
Englisch
Haven't found what you're looking for?
Wird geladen...